Oncology & Cancer

Patient decision aid beneficial in papillary thyroid cancer

(HealthDay) -- Patients with early-stage papillary thyroid cancer (PTC) may benefit from the use of a patient-directed computerized decision aid (DA) to provide medical knowledge and resolve decisional conflicts regarding ...

Oncology & Cancer

The role of fibronectin in BRAF-mutant thyroid cancer treatment

New research overseen by University of Colorado Cancer Center member Rebecca Schweppe, Ph.D., could lead to improved treatment for people with thyroid cancer characterized by a mutation in the BRAF gene—a mutation also ...

Oncology & Cancer

Familial component identified in papillary thyroid cancer

(HealthDay)—First-degree, second-degree, and third-degree relatives of patients diagnosed with papillary thyroid cancer (PTC) are at significantly increased risk of developing the disease, according to research published ...

Oncology & Cancer

Thyroid cancer—rising most rapidly among insured patients

The rapid increase in papillary thyroid cancer in the US, may not be linked to increase in occurrence, according to a head and neck surgeon at Dartmouth-Hitchcock Norris Cotton Cancer Center, instead it may be linked to an ...

page 2 from 4